<span id="midArticle_start"/>May 5 (Reuters) - CellaVision AB :
<span id="midArticle_0"/>* Q1 operating profit 10.5 million Swedish crowns ($1.25 million) versus 7.5 million crownsyear ago
<span id="midArticle_1"/>* Q1 net sales increased by 20 percent to 51.8 million crowns versus 43.2 crowns year ago
<span id="midArticle_2"/>
<span id="midArticle_3"/>Source text for Eikon:
<span id="midArticle_4"/>Further company coverage:
<span id="midArticle_5"/>($1 = 8.3900 Swedish crowns) (Gdynia Newsroom)
<span id="midArticle_6"/>
<span id="midArticle_0"/>* Q1 operating profit 10.5 million Swedish crowns ($1.25 million) versus 7.5 million crownsyear ago
<span id="midArticle_1"/>* Q1 net sales increased by 20 percent to 51.8 million crowns versus 43.2 crowns year ago
<span id="midArticle_2"/>
<span id="midArticle_3"/>Source text for Eikon:
<span id="midArticle_4"/>Further company coverage:
<span id="midArticle_5"/>($1 = 8.3900 Swedish crowns) (Gdynia Newsroom)
<span id="midArticle_6"/>
via Smart Health Shop Forum http://ift.tt/1GXmadN
No comments:
Post a Comment